Zhao; Wei-Qin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhao; Wei-Qin.The latest application filed is for "alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation".

Company Profile

0.9.15

Zhao; Wei-Qin - Germantown MD
Zhao; Wei-Qin - North Wales PA
Zhao; Wei-Qin - West Point PA
Zhao; Wei-Qin - Bethesda MD
Zhao; Wei-Qin - Gwynedd PA
Zhao, Wei-Qin - Gaithersburg MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Alzheimer's Disease Diagnosis Based On Mitogen-activated Protein Kinase Phosphorylation App 20160305961 - Zhao; Wei-Qin ; et al.	2016-10-20
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42 Grant 9,320,793 - Goure , et al. April 26, 2	2016-04-26
Antibodies, kit and method for detecting amyloid beta oligomers Grant 9,310,383 - Goure , et al. April 12, 2	2016-04-12
Anti-ADDL monoclonal antibody and uses thereof Grant 9,309,309 - Gaspar , et al. April 12, 2	2016-04-12
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation Grant 9,188,595 - Zhao , et al. November 17, 2	2015-11-17
Method For Treating A Disease Associated With Soluble, Oligomeric Species Of Amyloid Beta 1-42 App 20150320860 - Goure; William F. ; et al.	2015-11-12
Antibodies, kit and method for detecting amyloid beta oligomers Grant 9,176,151 - Goure , et al. November 3, 2	2015-11-03
Antibodies, Kit And Method For Detecting Amyloid Beta Oligomers App 20150260731 - Goure; William F. ; et al.	2015-09-17
Anti-addl Monoclonal Antibody And Uses Thereof App 20150023952 - Gaspar; Renee C. ; et al.	2015-01-22
Methods For Identifying Inhibitors Of Abeta42 Oligomers App 20140106380 - McCampbell; Alexander ; et al.	2014-04-17
Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease App 20130273545 - Zhao; Wei-Qin ; et al.	2013-10-17
Antibodies, Kit and Method for Detecting Amyloid Beta Oligomers App 20130130288 - Goure; William F. ; et al.	2013-05-23
Anti-addl Monoclonal Antibody And Uses Thereof App 20130115227 - Gaspar; Renee C. ; et al.	2013-05-09
Method For Treating A Disease Associated With Soluble, Oligomeric Species Of Amyloid Beta 1-42 App 20130089537 - Goure; William F. ; et al.	2013-04-11
Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance Grant 7,964,359 - Zhao , et al. June 21, 2	2011-06-21
Alzheimer's Disease Diagnosis Based on Mitogen-Activated Protein Kinase Phosphorylation App 20100278803 - Zhao; Wei-Qin ; et al.	2010-11-04
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation Grant 7,682,807 - Zhao , et al. March 23, 2	2010-03-23
Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's Disease App 20090029355 - Zhao; Wei-Qin ; et al.	2009-01-29
Compositions and methods for the enhancement of soluble amyloid beta oligomer (ADDL) uptake and clearance App 20070264669 - Zhao; Wei-Qin ; et al.	2007-11-15
Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation App 20050059092 - Zhao, Wei-Qin ; et al.	2005-03-17
Controlling attention and memory by altering neuronal carbonic anhydrase activity App 20020107267 - Sun, Miao-Kun ; et al.	2002-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.